Global Non-Invasive Blood Glucose Monitoring Devices Market Trends, Regulations And Competitive Landscape Outlook to 2027
Verfasser: yogesh on Wednesday, 18 January 2017Diabetes has evolved as one of the primary healthcare epidemic characterized by high sugar levels and principle cause of mortality worldwide. In 2014, World Health Organization (WHO) estimated 8.5% of adults living with diabetes. A diabetic person cannot either synthesize enough insulin (type 1 diabetes) or either does not make enough insulin or cannot effectively use the insulin produced by the body (type 2 diabetes). Another type of diabetes that occur in women during her pregnancy is gestational diabetes. However, gestational diabetes is usually resolved after delivery but can precede towards type 2 diabetes later in a women’s life. Most of the continuous glucose monitoring devices are invasive and involves use of needles leading to increased chance of infection. Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose. Certain evidences of hyperglycemia between measurements are however not recorded thus resulting in false or no representation of the blood glucose pattern. Noninvasive monitoring of glucose levels eliminates the need of painful pricking with increased risk of infection, and amount of damage caused to the finger tissue.